Delivery Order SPE2DB24D2101-SPE2DB25FKGFD

Award Date 1/13/25
Potential Completion Date 2/4/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication, with a ceiling value of $17,378.46. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a pharmaceutical product, with a ceiling value of $3,951.86 and a period of performance through April 14, 2025. The contract is a firm fixed-price, delivery order type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,903.74, is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication. The contract has an ultimate completion date of March 18, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product, and has a ceiling value of $23,711.16. The contract is a firm fixed-price delivery order with an ultimate completion date of January 29, 2025. This award is not designated as a set-aside...
This is a $5,616.51 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a specialty medication, to support military healthcare programs. The award has an ultimate completion date of February 4, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a $3,951.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The $5,792.82 order is for SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,711.16 firm-fixed-price contract is for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical, which serves as a...
This is a $12,613.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of SOMATULINE DEPOT 60 MG/0.2 ML 0.2ML, a specialty medication. The contract has a period of performance through March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The Defense Logistics Agency (DLA) awarded a $3,951.86 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKGFD
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,807.44 firm fixed-price contract is for the supply of the specialty medication SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML. It is not designated as a set-aside contract.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 10:08 AM